Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01525654 · ClinicalTrials.gov registry record · NA

Patient Rheumatoid Arthritis Social Support Study

A NA study, sponsored by Brigham and Women's Hospital.

Terminated
Registry status
NA
Development phase
65
Enrollment target

NCT01525654: Clinical Trial NA study, sponsored by Brigham and Women's Hospital.

NCT01525654 is a NA study that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01525654, a NA study, was terminated before completion, sponsored by Brigham and Women's Hospital.

TERMINATED
Registry status
NA
Development phase
65 participants
Enrollment target

Study Summary

The goal of PARASS is to develop a network of increased social support for Rheumatoid Arthritis (RA) patients that will improve patient outcomes and further promote understanding of RA among physicians and patients in the clinic community. This will be accomplished with the development and implementation of Buddy pairing and one -on- one informational support to be called Patient-to-Patient Connection.

Primary Outcome

functional status is measured by the Multi Dimensional Health Assessment Questionnaire doing scale and flare activity

Interventions

  • BEHAVIORAL Peer Support Program

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2009-03
Est. Completion 2019-03
Phase NA
Brigham and Women's Hospital

937 total trials

Why NCT01525654 stopped before completion

NCT01525654 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Peer Support Program is the first listed.

NCT01525654 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01525654 about?

NCT01525654 is a clinical study titled "Patient Rheumatoid Arthritis Social Support Study". The goal of PARASS is to develop a network of increased social support for Rheumatoid Arthritis (RA) patients that will improve patient outcomes and further promote understanding of RA among physicians and patients in the clinic community. This will be accomplished with the development and implement...

What is the current status of trial NCT01525654?

This trial is currently terminated. It is a NA study. The enrollment target is 65 participants. The study started on 2009-03. Estimated completion is 2019-03.

What interventions are being tested in trial NCT01525654?

The interventions under investigation include: Peer Support Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT01525654?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01525654's enrollment target sits among peer trials

65 1144th of 2000 higher than 854 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03366116 · 65 participants · Phase 1

    5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

  • NCT03603730 · 65 participants · NA

    Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

  • NCT03796559 · 65 participants · NA

    Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

  • NCT03993106 · 65 participants · Phase 2

    A Study of sEphB4-HSA in Kaposi Sarcoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01525654, the US trial registry maintained by the National Library of Medicine. NCT01525654 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.